What is the 13F Pro Quality Score for SRRK?

13F Pro ranks Scholar Rock Holding Corp (SRRK) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View SRRK's current score at https://13fpro.ai/research/SRRK (free sign-up required for the full ranking).

Which hedge funds own the most SRRK stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of SRRK include FMR, Siren, L.L.C., Redmile Group,. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/SRRK as soon as new 13F filings post.

Where does 13F Pro source SRRK data?

All Scholar Rock Holding Corp fundamentals and ownership data come directly from SEC EDGAR. Scholar Rock Holding Corp files with the SEC under CIK 1727196. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is SRRK in?

Scholar Rock Holding Corp (SRRK) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is SRRK research updated on 13F Pro?

SRRK's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Scholar Rock Holding Corp(SRRK)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1727196 SRRK stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

SRRK Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Scholar Rock Holding Corp (SRRK), a Healthcare sector company. SRRK is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), Scholar Rock Holding Corp reports net income of $-105.5M, free cash flow of $-82.2M. Top institutional holders of SRRK by reported 13-F value include FMR, Siren, L.L.C., Redmile Group,, based on the most recent SEC filings. SRRK trades on the Nasdaq exchange and files with the SEC under CIK 1727196. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SRRK daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Scholar Rock Holding Corp directly from SEC EDGAR. Scholar Rock Holding Corp's 13F Pro composite quality score has ranged between 11 and 29 since 2021, currently 23.3 — an improving long-term trajectory across 16 quarterly and live scoring snapshots.

Revenue

Q1 2026

$0.00

Net Income

Q1 2026

$-105.5M

Free Cash Flow

Q1 2026

$-82.2M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

$0.00FY 2025

FY22 $33.2MFY23 —FY24 —FY25 $0.00

Net Income

-53.5% YoY

$-377.9MFY 2025

FY22 $-134.5MFY23 $-165.8MFY24 $-246.3MFY25 $-377.9M

Operating Income

-52.6% YoY

$-384.6MFY 2025

FY22 $-134.4MFY23 $-171.3MFY24 $-252.1MFY25 $-384.6M

EPS (Diluted)

-33.2% YoY

$-3.29FY 2025

FY22 $-2.26FY23 $-1.99FY24 $-2.47FY25 $-3.29

Total Assets

-14.9% YoY

$404.3MFY 2025

FY22 $358.2MFY23 $311.0MFY24 $474.9MFY25 $404.3M

Total Debt

+98.8% YoY

$99.7MFY 2025

FY22 $51.0MFY23 $52.3MFY24 $50.1MFY25 $99.7M

Op. Cash Flow

-49.3% YoY

$-300.0MFY 2025

FY22 $-132.7MFY23 $-145.2MFY24 $-200.9MFY25 $-300.0M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019
Revenue	$0.00	—	—	$33.2M +115.5%	$15.4M -24.8%	$20.5M
Net Income	$-377.9M -53.5%	$-246.3M -48.6%	$-165.8M -23.3%	$-134.5M -55.5%	$-86.5M -69.6%	$-51.0M
Operating Income	$-384.6M -52.6%	$-252.1M -47.1%	$-171.3M -27.5%	$-134.4M -54.7%	$-86.9M -59.3%	$-54.5M
EPS (Diluted)	$-3.29 -33.2%	$-2.47 -24.1%	$-1.99 +11.9%	$-2.26 +19.6%	$-2.81	—
Total Assets	$404.3M -14.9%	$474.9M +52.7%	$311.0M -13.2%	$358.2M -7.8%	$388.3M +97.7%	$196.4M
Total Debt	$99.7M +98.8%	$50.1M -4.2%	$52.3M +2.6%	$51.0M +96.2%	$26.0M	—
Operating Cash Flow	$-300.0M -49.3%	$-200.9M -38.4%	$-145.2M -9.4%	$-132.7M -120.2%	$-60.3M +4.5%	$-63.1M

AI Insight: SRRK Financial Trends

Scholar Rock remains pre-revenue with accelerating cash burn and debt nearly quadrupling to $197M in Q1 2026, pressuring a shrinking equity base.

• Operating losses widened from $-59M in Q2 2024 to $-102M in Q1 2026, reflecting sustained and growing R&D investment.

• Total debt surged from $50M in Q2 2024 to $197M in Q1 2026, with a sharp $97M jump in the latest quarter alone.

• Equity rose to $276M in Q1 2026 from $245M in Q4 2025, likely reflecting new capital raises offsetting net losses.

• Operating cash outflow hit $-82M in Q1 2026, the largest single-quarter burn in the eight-quarter dataset.

⚠ Debt nearly doubled to $197M in Q1 2026 with zero revenue — debt serviceability hinges entirely on future financing rounds.

⚠ Equity has declined from $369M in Q4 2024 to $276M in Q1 2026 despite apparent capital raises; cash burn is outpacing inflows.

⚠ No revenue recorded through Q1 2026 — any catalyst triggering first commercial or milestone revenue would be a key inflection point.

AI Insight: SRRK Ratio Trends

SRRK remains deeply loss-making with no margin data available, while leverage has surged back to multi-quarter highs in Q1 2026.

• D/E ratio rose sharply from 0.14 in Q4 2024 to 0.71 in Q1 2026, reversing a period of deleveraging.

• ROE swung from -72.1% in Q4 2024 to -152.9% in Q1 2026, signaling worsening equity returns.

• ROA deteriorated from -56.0% in Q4 2024 to -78.8% in Q1 2026, reflecting persistent and deepening asset losses.

⚠ D/E at 0.71 in Q1 2026 matches TTM level — continued leverage build could pressure the balance sheet as losses persist.

⚠ OpMargin and NPM are entirely absent across all periods; disclosure improvement needed to assess operational trajectory.

Get alerted when SRRK's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Scholar Rock Holding Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of SRRK

FMR LLC
$847.7M17,243,152 sh
Siren, L.L.C.
$532.2M10,825,013 sh
Redmile Group, LLC
$445.7M9,066,621 sh
BlackRock, Inc.
$367.2M7,469,293 sh
Samsara BioCapital, LLC
$339.1M6,897,652 sh
WELLINGTON MANAGEMENT GROUP LLP
$330.2M6,717,655 sh
Orbis Allan Gray Ltd
$205.5M4,179,983 sh
STATE STREET CORP
$198.2M4,031,317 sh
VANGUARD CAPITAL MANAGEMENT LLC
$191.3M3,891,347 sh
Bellevue Group AG
$176.2M3,584,573 sh

Fund	Value	Shares
FMR LLC	$847.7M	17,243,152
Siren, L.L.C.	$532.2M	10,825,013
Redmile Group, LLC	$445.7M	9,066,621
BlackRock, Inc.	$367.2M	7,469,293
Samsara BioCapital, LLC	$339.1M	6,897,652
WELLINGTON MANAGEMENT GROUP LLP	$330.2M	6,717,655
Orbis Allan Gray Ltd	$205.5M	4,179,983
STATE STREET CORP	$198.2M	4,031,317
VANGUARD CAPITAL MANAGEMENT LLC	$191.3M	3,891,347
Bellevue Group AG	$176.2M	3,584,573

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put SRRK on your watchlist

Track score changes the day Scholar Rock Holding Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is SRRK a good stock to buy?

13F Pro's AI-powered analysis of Scholar Rock Holding Corp (SRRK) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SRRK are available on the SRRK stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own SRRK?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SRRK. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Scholar Rock Holding Corp's investment landscape.